FDA approves new ALS drug that costs $158,000 a year
September 30, 2022 at 13:12 PM EDT
Amylyx's new treatment for amyotrophic lateral sclerosis received funding raised during 2014's Ice Bucket Challenge.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
